“The levels of low-density lipoprotein cholesterol, total cholesterol, triglycerides, and high-density lipoprotein cholesterol in patients’ serum after treatment were the primary endpoint.”
there’s big pharma treating numbers again ... gotta love the fact that the study end-points don’t include functional data such as absolute reduction in overall mortality, absolute reduction in overall cardiovascular disease, or absolute reduction in cerebral infarct ...
but hey, we can get some numbers to change, whether that means anything or not other than possibly our stock price ...
come to think of it, how long will it be before the stock price itself becomes the endpoint to a drug study? really, why not test for what really matter? get right to the bottom of things?
I thought the Ancel Keys research was debunked years ago.